These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2119247)

  • 21. Biologicals for cancer treatment: interferons.
    Oldham RK
    Hosp Pract (Off Ed); 1985 Dec; 20(12):71-4, 78-81, 85-6 passim. PubMed ID: 2415542
    [No Abstract]   [Full Text] [Related]  

  • 22. [In vivo anti-tumour efficacy of tumour necrosis factor and interferon- alpha, -gamma on human renal cell carcinoma heterotransplanted in nude mice].
    Onishi T; Machida T; Masuda F; Iizuka N; Nakauchi K; Furuta N; Shirakawa H
    Nihon Gan Chiryo Gakkai Shi; 1990 Aug; 25(8):1571-8. PubMed ID: 2121869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antineoplastic effects of interferons].
    Shimoyama M
    Nihon Rinsho; 1986 Feb; 44(2):395-402. PubMed ID: 2422409
    [No Abstract]   [Full Text] [Related]  

  • 24. Synergistic therapeutic effect of combination therapy with OK-432 and interferon-alpha or -gamma on Meth-A ascites tumor in BALB/c mice.
    Mizushima Y; Morikage T; Hirata H; Sato M; Sakamoto K; Yano S
    J Biol Response Mod; 1988 Aug; 7(4):371-83. PubMed ID: 3139841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cytokines in tumor therapy].
    Kalden JR
    Onkologie; 1987 Aug; 10(4):240-4. PubMed ID: 3118282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Interferon in the treatment of hairy cell leukemia].
    Deptała A
    Acta Haematol Pol; 1989; 20(1):86-92. PubMed ID: 2515708
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunological monitoring and clinical trials of biological response modifiers.
    Urba WJ; Baseler MW
    Cancer Chemother Biol Response Modif; 1990; 11():281-302. PubMed ID: 2121208
    [No Abstract]   [Full Text] [Related]  

  • 28. Interferons in therapeutics.
    Wardle EN
    Br J Hosp Med; 1989 Jan; 41(1):99. PubMed ID: 2493959
    [No Abstract]   [Full Text] [Related]  

  • 29. [Antitumor effect of interferons].
    Ebina T; Saito M
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):24-35. PubMed ID: 6421241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biologicals and biological response modifiers: new approaches to cancer treatment.
    Oldham RK
    Cancer Invest; 1985; 3(1):53-70. PubMed ID: 3918773
    [No Abstract]   [Full Text] [Related]  

  • 31. Lymphokines and monokines in anti-cancer therapy.
    Fiers W; Brouckaert P; Devos R; Fransen L; Leroux-Roels G; Remaut E; Suffys P; Tavernier J; Van der Heyden J; Van Roy F
    Cold Spring Harb Symp Quant Biol; 1986; 51 Pt 1():587-95. PubMed ID: 3107882
    [No Abstract]   [Full Text] [Related]  

  • 32. Hyperthermia with simultaneous administration of interferon using established human renal carcinoma heterotransplanted in nude mice.
    Onishi T; Machida T; Mori Y; Iizuka N; Masuda F; Mochizuki S; Tsukamoto H; Harada N
    Br J Urol; 1989 Mar; 63(3):227-32. PubMed ID: 2495145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response to the combined administration of interferons alpha and gamma after failure of single interferon therapy in chronic myelogenous leukaemia.
    Kloke O; Becher R; Niederle N
    Blut; 1987 Nov; 55(5):453-8. PubMed ID: 3118992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapeutic procedure in hairy cell leukemia].
    von Wussow P
    Klin Wochenschr; 1987 Jul; 65(14):677-80. PubMed ID: 3114549
    [No Abstract]   [Full Text] [Related]  

  • 35. Potentiation of antiproliferative activity by mixtures of human recombinant IFN-alpha 2 and -gamma on growth of human cancer nodules maintained in continuous organotypic culture.
    Martyre MC; Beaupain R; Falcoff E
    Eur J Cancer Clin Oncol; 1987 Jul; 23(7):917-22. PubMed ID: 3117562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of urologic neoplasms with interferon].
    Kumanov Kh; Tsvetkov M; Neĭkov K
    Khirurgiia (Sofiia); 1989; 42(5):1-7. PubMed ID: 2483187
    [No Abstract]   [Full Text] [Related]  

  • 37. [Interferon].
    Smogorzewska E
    Probl Med Wieku Rozwoj; 1984; 13():176-84. PubMed ID: 6085167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CML: new biologic therapies, endpoints and questions.
    Martin A; Cheson BD
    Oncology (Williston Park); 1987 Sep; 1(7):12-3, 16. PubMed ID: 3152809
    [No Abstract]   [Full Text] [Related]  

  • 39. The anti-tumor effect of recombinant interferon alpha or gamma is influenced by tumor location.
    Brunda MJ; Sulich V; Bellantoni D
    Int J Cancer; 1987 Dec; 40(6):807-10. PubMed ID: 3121522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of multiple sclerosis with various interferons: the cons.
    Johnson KP
    Neurology; 1988 Jul; 38(7 Suppl 2):62-5. PubMed ID: 3133576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.